Skip to main content

Table 12 The cost-effectiveness analysis in the 12-month intervention period (reversion rate)

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group

C (yuan)

E (%)

C/E

ΔC/ΔE

The treatment group

21156020.3

41.8

506124.9

 

The control group

18815209.0

27.8

676806.1

167213.7